TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Transenterix Inc(NYSEMKT:TRXC) Investor Investigation Over Potential Securities Laws Violations Announced

  • If you purchased shares of Transenterix Inc(NYSEMKT:TRXC), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Transenterix Inc
Security
NYSEMKT: TRXC

Summary

April 25, 2016 (Shareholders Foundation) - An investigation on behalf of investors of Transenterix Inc(NYSEMKT:TRXC) shares over potential securities laws violations by Transenterix and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Transenterix Inc(NYSEMKT:TRXC) concerning whether a series of statements by Transenterix regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On April 20, 2016, Transenterix Inc announced that the Food and Drug Administration ('FDA') notified Transenterix Inc on April 19, 2016 of its determination that the 'SurgiBot System does not meet the criteria for substantial equivalence based upon the data and information submitted by TransEnterix in its 510(k) submission.

Shares of Transenterix Inc(NYSEMKT:TRXC) declined to a slow as $1.28 per share on April 21, 2016.

Start Monitoring Your Investments